Search

Your search keyword '"Grant K. Hunter"' showing total 4 results
Start Over Author "Grant K. Hunter" Journal international journal of radiation oncology*biology*physics
4 results on '"Grant K. Hunter"'

1. Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813

Author

W.A. Yung, Susan M. Chang, Aline Paixão Becker, I Robins, Erica Hlavin Bell, Jean-Paul Bahary, Arnab Chakravarti, Helen A. Shih, Brian D. Kavanagh, Jessica Fleming, Lynn S. Ashby, Stephanie L. Pugh, Grant K. Hunter, Christopher J. Schultz, Cynthia Timmers, Maria Werner-Wasik, and Joseph P. McElroy

Subjects
Cancer Research, Radiation, IDH1, Oncology, business.industry, Promoter methylation, Mutation (genetic algorithm), Cancer research, Medicine, Radiology, Nuclear Medicine and imaging, business
Published
2021

2. Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT + PCV in High-risk Low-grade Gliomas

Author

Aline Paixão Becker, Nadia N. Laack, Stanley Z. Gertler, Minhee Won, David B. Johnson, Jessica Fleming, Arnab Chakravarti, Joseph P. McElroy, Erica Hlavin Bell, Ian R. Crocker, D. Brachman, Minesh P. Mehta, Christopher J. Schultz, Albert Murtha, Grant K. Hunter, and Edward G. Shaw

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Radiation, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Subgroup analysis, business
Published
2019
Full Text
View/download PDF

3. Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma

Author

R.A. Rabinovitch, Arnab Chakravarti, Susan M. Chang, Erica Hlavin Bell, Joseph Bovi, Emad F. Youssef, Steven P. Howard, W.A. Yung, Jean-Paul Bahary, Y. Chen, Helen A. Shih, Jessica Fleming, Peixin Zhang, Grant K. Hunter, and Joseph P. McElroy

Subjects
Oncology, Cancer Research, Nitrosourea, medicine.medical_specialty, Radiation, Temozolomide, business.industry, medicine.medical_treatment, medicine.disease, Radiation therapy, chemistry.chemical_compound, chemistry, Glioma, Internal medicine, Gene expression, medicine, Overall survival, Radiology, Nuclear Medicine and imaging, business, medicine.drug
Published
2018
Full Text
View/download PDF

4. MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide

Author

Jean-Paul Bahary, Erica Hlavin Bell, Kenneth Aldape, Karl Belanger, Lynn S. Ashby, Gregory Cairncross, W.A. Yung, Arnab Chakravarti, Jessica Fleming, Joseph P. McElroy, Helen A. Shih, Malika Siker, Susan M. Chang, Yuhchyau Chen, Grant K. Hunter, Minhee Won, Steven P. Howard, Carol A. Dolinskas, Brian D. Kavanagh, and Mark R. Gilbert

Subjects
Oncology, Cancer Research, Nitrosourea, medicine.medical_specialty, Radiation, Temozolomide, business.industry, medicine.disease, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, Promoter methylation, Overall survival, Medicine, Radiology, Nuclear Medicine and imaging, business, 030217 neurology & neurosurgery, medicine.drug, Anaplastic astrocytoma
Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results